The Process to Discover and Develop Biomarkers for Cancer: A Work in Progress

被引：21

作者：

Ransohoff, David F. ^{[1
,2
]}

机构：

[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA

[2] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2008年 / 100卷 / 20期

关键词：

D O I：

10.1093/jnci/djn339

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1419 / U1

页数：2

共 8 条

[1] Research issues and strategies for genomic and proteomic biornarker discovery and validation: a statistical perspective [J].

Feng, Z ;

Prentice, R ;

Srivastava, S .

PHARMACOGENOMICS, 2004, 5 (06) :709-719

[2]

Knottnerus JA, 2002, EVIDENCE BASE CLIN D, P39

[3] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

[4] Phases of biomarker development for early detection of cancer [J].

Pepe, MS ;

Etzioni, R ;

Feng, ZD ;

Potter, JD ;

Thompson, ML ;

Thornquist, M ;

Winget, M ;

Yasui, Y .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1054-1061

[5]

PEPE MS, 2008, J NCI, V20, P1432

[6] Assessment of serum proteomics to detect large colon adenomas [J].

Ransohoff, David F. ;

Martin, Christopher ;

Wiggins, Wesley S. ;

Hitt, Ben A. ;

Keku, Temitope O. ;

Galanko, Joseph A. ;

Sandler, Robert S. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (08) :2188-2193

[7] How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design [J].

Ransohoff, David F. .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (12) :1205-1219

[8]

WINSTEAD ER, 2008, NCI CANC B, V5, P5

← 1 →